These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


194 related items for PubMed ID: 11445185

  • 1. The in vivo relevance of the varied channel-blocking properties of uncompetitive NMDA antagonists: tests on spinal neurones.
    Jones MW, McClean M, Parsons CG, Headley PM.
    Neuropharmacology; 2001 Jul; 41(1):50-61. PubMed ID: 11445185
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the effects of MK-801, ketamine and memantine on responses of spinal dorsal horn neurones in a rat model of mononeuropathy.
    Suzuki R, Matthews EA, Dickenson AH.
    Pain; 2001 Mar; 91(1-2):101-9. PubMed ID: 11240082
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo.
    Parsons CG, Quack G, Bresink I, Baran L, Przegalinski E, Kostowski W, Krzascik P, Hartmann S, Danysz W.
    Neuropharmacology; 1995 Oct; 34(10):1239-58. PubMed ID: 8570022
    [Abstract] [Full Text] [Related]

  • 4. Memantine selectively depresses NMDA receptor-mediated responses of ratspinal neurones in vivo.
    Herrero JF, Headley PM, Parsons CG.
    Neurosci Lett; 1994 Jan 03; 165(1-2):37-40. PubMed ID: 7517024
    [Abstract] [Full Text] [Related]

  • 5. Stimulus intensity, cell excitation and the N-methyl-D-aspartate receptor component of sensory responses in the rat spinal cord in vivo.
    Chizh BA, Cumberbatch MJ, Herrero JF, Stirk GC, Headley PM.
    Neuroscience; 1997 Sep 03; 80(1):251-65. PubMed ID: 9252236
    [Abstract] [Full Text] [Related]

  • 6. Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan).
    Parsons CG, Gruner R, Rozental J, Millar J, Lodge D.
    Neuropharmacology; 1993 Dec 03; 32(12):1337-50. PubMed ID: 8152525
    [Abstract] [Full Text] [Related]

  • 7. Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists.
    Grant KA, Colombo G, Grant J, Rogawski MA.
    Neuropharmacology; 1996 Dec 03; 35(12):1709-19. PubMed ID: 9076750
    [Abstract] [Full Text] [Related]

  • 8. Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices.
    Frankiewicz T, Potier B, Bashir ZI, Collingridge GL, Parsons CG.
    Br J Pharmacol; 1996 Feb 03; 117(4):689-97. PubMed ID: 8646415
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A novel class of amino-alkylcyclohexanes as uncompetitive, fast, voltage-dependent, N-methyl-D-aspartate (NMDA) receptor antagonists--in vitro characterization.
    Gilling K, Jatzke C, Wollenburg C, Vanejevs M, Kauss V, Jirgensons A, Parsons CG.
    J Neural Transm (Vienna); 2007 Feb 03; 114(12):1529-37. PubMed ID: 17728997
    [Abstract] [Full Text] [Related]

  • 14. Memantine and the amino-alkyl-cyclohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists--in vitro characterisation.
    Parsons CG, Danysz W, Quack G.
    Amino Acids; 2000 Feb 03; 19(1):157-66. PubMed ID: 11026484
    [Abstract] [Full Text] [Related]

  • 15. Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice.
    Geter-Douglass B, Witkin JM.
    Psychopharmacology (Berl); 1999 Oct 03; 146(3):280-9. PubMed ID: 10541728
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Memantine block depends on agonist presentation at the NMDA receptor in substantia nigra pars compacta dopamine neurones.
    Wild AR, Akyol E, Brothwell SL, Kimkool P, Skepper JN, Gibb AJ, Jones S.
    Neuropharmacology; 2013 Oct 03; 73():138-46. PubMed ID: 23727219
    [Abstract] [Full Text] [Related]

  • 18. The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801.
    Rammes G, Mahal B, Putzke J, Parsons C, Spielmanns P, Pestel E, Spanagel R, Zieglgänsberger W, Schadrack J.
    Neuropharmacology; 2001 May 03; 40(6):749-60. PubMed ID: 11369029
    [Abstract] [Full Text] [Related]

  • 19. Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization.
    Glasgow NG, Povysheva NV, Azofeifa AM, Johnson JW.
    J Neurosci; 2017 Oct 04; 37(40):9686-9704. PubMed ID: 28877967
    [Abstract] [Full Text] [Related]

  • 20. The antiallodynic effect of NMDA antagonists in neuropathic pain outlasts the duration of the in vivo NMDA antagonism.
    Christoph T, Schiene K, Englberger W, Parsons CG, Chizh BA.
    Neuropharmacology; 2006 Jul 04; 51(1):12-7. PubMed ID: 16616769
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.